fda warning letters compounded semaglutide tirzepatide 2025 weight loss injections — knock-offs are not the same – Partnership for Safe Medicines Why the FDA Issued 30

If your weight loss plateaus or you dont reach your goal, we may recommend switching to tirzepatide

The Godman study shows this is not true

But starting July 1, a new program allows some older Americans who use Medicare Part D to receive select GLP-1 medications for $50 per month

Why do they not interact

As semaglutide reduces weight, this risk should theoretically decrease, but the transition period, where rapid weight loss causes fluid shifts and muscle wasting, may temporarily increase risk before the long-term protective effects kick in

Explore the library and advance your research #DrugRepurposing #DrugDiscovery #PharmaResearch #OffPatentDrugs To view or add a comment, sign in TCG's analysis of this quarter's FDA enforcement trends is here